Cargando…

Patterns of participation over four rounds of annual fecal immunochemical test-based screening for colorectal cancer: what predicts rescreening?

BACKGROUND: Participation at the recommended intervals is critical for screening to be effective in reducing colorectal cancer (CRC) incidence. This study describes patterns of screening participation over four rounds of fecal immunochemical testing (FIT) to identify whether demographic variables an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Osborne, Joanne M., Wilson, Carlene, Duncan, Amy, Cole, Stephen R., Flight, Ingrid, Turnbull, Deborah, Hughes, Donna L., Young, Graeme P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540393/ https://www.ncbi.nlm.nih.gov/pubmed/28764667 http://dx.doi.org/10.1186/s12889-017-4634-8

Ejemplares similares

Comparison of mailed invitation strategies to improve fecal occult blood test participation in men: protocol for a randomized controlled trial
por: Duncan, Amy, et al.
Publicado: (2013)

Behavioural and demographic predictors of adherence to three consecutive faecal occult blood test screening opportunities: a population study
por: Duncan, Amy, et al.
Publicado: (2014)

Thinking Style as a Predictor of Men’s Participation in Cancer Screening
por: McGuiness, Clare E., et al.
Publicado: (2016)

A randomised controlled trial of personalised decision support delivered via the internet for bowel cancer screening with a faecal occult blood test: the effects of tailoring of messages according to social cognitive variables on participation
por: Wilson, Carlene J, et al.
Publicado: (2015)

Implementation of population screening for colorectal cancer by repeated Fecal Immunochemical Test (FIT): third round
por: Stegeman, Inge, et al.
Publicado: (2012)

Mammography Rescreening Among Older California Women
por: Sabogal, Fabio, et al.
Publicado: (2001)

Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening
por: van der Vlugt, Manon, et al.
Publicado: (2017)

Program Components and Results From an Organized Colorectal Cancer Screening Program Using Annual Fecal Immunochemical Testing
por: Selby, Kevin, et al.
Publicado: (2022)

Assessment of the Value of Rescreening for Syphilis in the Third Trimester of Pregnancy
por: Edwards, Rodney K., et al.
Publicado: (2006)

Benefits of rescreening newborns of mothers affected by autoimmune hypothyroidism
por: Cavarzere, Paolo, et al.
Publicado: (2022)

Demographic, social cognitive and social ecological predictors of intention and participation in screening for colorectal cancer
por: Gregory, Tess A, et al.
Publicado: (2011)

The impact of sample type and procedural attributes on relative acceptability of different colorectal cancer screening regimens
por: Osborne, Joanne M, et al.
Publicado: (2018)

Acute HIV Infection in Pregnancy: The Case for Third Trimester Rescreening
por: Wertz, Jocelyn, et al.
Publicado: (2011)

Utilizing RE-AIM to scope potential for feasible immigrant cancer literacy education
por: Hughes-Barton, Donna, et al.
Publicado: (2023)

Lifestyle predictors for non-participation and outcome in the second round of faecal immunochemical test in colorectal cancer screening
por: Knudsen, Markus Dines, et al.
Publicado: (2017)

Exploring the Potential of Anticipated Regret as an Emotional Cue to Improve Bowel Cancer Screening Uptake
por: Zajac, Ian T., et al.
Publicado: (2017)

Web-Based Communication Strategies Designed to Improve Intention to Minimize Risk for Colorectal Cancer: Randomized Controlled Trial
por: Wilson, Carlene, et al.
Publicado: (2018)

Protocol for population testing of an Internet-based Personalised Decision Support system for colorectal cancer screening
por: Wilson, Carlene J, et al.
Publicado: (2010)

A large proportion of fecal immunochemical test-positive participants in colorectal cancer screening is symptomatic
por: de Klerk, Clasine M, et al.
Publicado: (2017)

Congenital syphilis: Missed opportunities and the case for rescreening during pregnancy and at delivery
por: O’Connor, Nicola P., et al.
Publicado: (2020)

Comparisons of Factors Influencing Cancer Rescreening Intention in Middle-Aged and Elderly
por: Kim, Hee-Jung
Publicado: (2021)

Neonatal Hearing Rescreening in a Second-Level Hospital: Problems and Solutions
por: Gómez-Delgado, Marta, et al.
Publicado: (2023)

Participant uptake of the fecal immunochemical test decreases with the two-sample regimen compared with one-sample FIT
por: Mosen, David M., et al.
Publicado: (2014)

Preference and Experience of Colonic Examination for Participants Presenting to Hospitals with a Positive Fecal Immunochemical Test Result
por: Kato, Takashi, et al.
Publicado: (2020)

The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening
por: Kooyker, Arthur I., et al.
Publicado: (2020)

Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis
por: Kim, Dong Ju, et al.
Publicado: (2018)

Which Fecal Immunochemical Test Should I Choose?
por: Daly, Jeanette M., et al.
Publicado: (2017)

Profiling small RNAs in fecal immunochemical tests: is it possible?
por: Birkeland, Einar, et al.
Publicado: (2023)

Fecal Immunochemical Tests Detect Screening Participants with Multiple Advanced Adenomas Better than T1 Colorectal Cancers
por: Gies, Anton, et al.
Publicado: (2021)

The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design
por: Wisse, P. H. A., et al.
Publicado: (2022)

Accuracy of H. pylori fecal antigen test using fecal immunochemical test (FIT)
por: Nieuwenburg, S. A. V., et al.
Publicado: (2021)

Assessment of disease activity by fecal immunochemical test in ulcerative colitis
por: Ryu, Dae Gon, et al.
Publicado: (2016)

Are Hemorrhoids Associated with False-Positive Fecal Immunochemical Test Results?
por: Kim, Nam Hee, et al.
Publicado: (2017)

Screening for Colorectal Cancer by Immunochemical Fecal Occult Blood Testing
por: Saito, Hiroshi
Publicado: (1996)

Improving Adenoma Detection Rates: The Role of the Fecal Immunochemical Test
por: Nwankwo, Eugene C, et al.
Publicado: (2021)

Fecal immunochemical test as a biomarker for inflammatory bowel diseases: can it rival fecal calprotectin?
por: Kato, Jun, et al.
Publicado: (2016)

Fecal Immunochemical Tests for Colorectal Cancer Screening: Is Fecal Sampling from Multiple Sites Necessary?
por: Amitay, Efrat L., et al.
Publicado: (2019)

Clinical implications of fecal calprotectin and fecal immunochemical test on mucosal status in patients with ulcerative colitis
por: Ryu, Dae Gon, et al.
Publicado: (2019)

A Blood Test for Methylated BCAT1 and IKZF1 vs. a Fecal Immunochemical Test for Detection of Colorectal Neoplasia
por: Symonds, Erin L, et al.
Publicado: (2016)

Patients and Providers Are Amenable to Fecal Immunochemical Testing by Digital Rectal Exam
por: Naidu, Harini, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m43iscp238q2jf5667p4be7i72